Menu
Search
|

Menu

Close
X

Medpace Holdings Inc MEDP.OQ (NASDAQ Stock Exchange Global Select Market)

36.69 USD
-- (--)
As of Feb 22
chart
Previous Close 36.69
Open --
Volume --
3m Avg Volume 84,613
Today’s High --
Today’s Low --
52 Week High 39.61
52 Week Low 21.76
Shares Outstanding (mil) 37.43
Market Capitalization (mil) 1,373.30
Forward P/E 53.56
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.86 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY17
430
FY16
422
FY15
188
EPS (USD)
FY17
0.890
FY16
0.345
FY15
-0.220
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
53.56
34.59
Price to Sales (TTM)
vs sector
3.18
8.08
Price to Book (MRQ)
vs sector
2.49
5.24
Price to Cash Flow (TTM)
vs sector
17.76
25.98
Total Debt to Equity (MRQ)
vs sector
38.48
15.60
LT Debt to Equity (MRQ)
vs sector
35.67
12.18
Return on Investment (TTM)
vs sector
3.48
13.67
Return on Equity (TTM)
vs sector
4.78
15.40

EXECUTIVE LEADERSHIP

August Troendle
Chairman of the Board, President, Chief Executive Officer, Since
Salary: $410,000.00
Bonus: --
Jesse Geiger
Chief Financial Officer, Chief Operating Officer - Laboratory Operations, Since
Salary: $341,666.00
Bonus: $200,000.00
Susan Burwig
Executive Vice President - Operations, Since 2017
Salary: $377,932.00
Bonus: $132,587.00
Penelope Bucknell
Vice President - Human Resources, Since
Salary: --
Bonus: --
Stephen Ewald
General Counsel, Corporate Secretary, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

5375 Medpace Way
CINCINNATI   OH   45227-1543

Phone: +1513.5799911
Site:

Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

SPONSORED STORIES